-
Compartmented Gel Capsule Developed for Multi-Drug Delivery
U.S. and Chinese researchers have designed a multiple-compartment gel capsule that could simultaneously deliver drugs of different types. A description of their research is published online in the journal Macromolecular Rapid Communications (paid subscription required). L. Andrew Lyon, a chemistry professor at Georgia Institute of Technology in Atlanta and Xiaobo Hu, a former visiting scholar…
-
Sanofi, Rib-X to Collaborate on New Types of Antibiotics
The global pharmaceutical firm Sanofi has agreed to jointly develop new antibiotic technology with the biotechnology company Rib-X Pharmaceuticals in New Haven, Connecticut. The agreement includes an option for Sanofi to license the technology from Rib-X that treats resistant pathogens. Rib-X’s RX-04 program is developing new types of antibiotics aimed at drug-resistant pathogens, which the…
-
Lasers, Electric Fields Aid Lab-on-a-Chip Technology
Researchers from universities in the U.S., U.K., and China are developing new processes that combine a laser and electric fields to manipulate fluids and tiny particles such as bacteria, viruses, and DNA on miniature chip-sized analytic devices. These advances, with applications ranging from drug manufacturing to food safety, are described in the current issue of…
-
Prof. Develops Anti-Microbial Technology for Fabrics
A University of Georgia researcher has invented an anti-microbial technology that can turn medical linens and clothing germ-free. Jason Locklin (right), a member of the chemistry and engineering faculties at the university’s Athens campus, published results of his and colleagues’ research last month in the journal ACS Applied Materials & Interfaces; paid subscription required. Locklin’s discovery…
-
Algorithm Being Developed to Limit Small Airplane Collisions
A postdoc and colleagues at Massachusetts Institute of Technology are developing an algorithm for a tracking system to predict and prevent collisions between small aircraft. The MIT team will present early results of its research in October at the 30th Digital Avionics Systems Conference in Seattle. The Federal Aviation Administration (FAA) has mandated that by…
-
Trial Shows Drug Combo Extends Time Without Tumor Growth
The global pharmaceutical company Novartis says its drug everolimus, when used in combination with exemestane, extended the time without tumor growth, when compared to placebo plus exemestane, in women with advanced breast cancer. The study included postmenopausal women with metastatic breast cancer whose disease has progressed, despite initial endocrine therapy. Novartis says the clinical trial…
-
Anti-Smoking Drug Raises Risk of Heart Problems
Researchers at Johns Hopkins University, Wake Forest University, and University of East Anglia in the U.K. found healthy tobacco users that take a leading smoking cessation drug face a notably greater chance of hospitalization from heart problems, compared to those taking a placebo. The findings appear in the current issue of the Canadian Medical Association…
-
Light Posting Today
Because of the Independence Day holiday today in the USA, we will have fewer items than usual. For those in the USA, enjoy your Fourth. We’ll be back tomorrow. * * *
-
Foods with Baked Milk Can Build Children’s Dairy Tolerance
Researchers at Mount Sinai School of Medicine in New York have found that adding increasing amounts of foods with baked milk into the diets of children who have milk allergies helped most of them outgrow their allergies. The findings appear in the 23 May issue of the Journal of Allergy and Clinical Immunology. The team…
-
University Spin-Off to Develop Semiconductor Power Devices
Anvil Semiconductors Ltd, a company created by University of Warwick in Coventry, U.K., will develop silicon carbide (SiC) semiconductor power switches that promise to be smaller and more efficient than devices built on traditional silicon. The company was founded by Warwick engineering faculty Phil Mawby and Peter Ward, who designed the company’s development technology in…